PatientPlus articles are written by UK doctors and are based on research evidence, UK and European Guidelines. They are designed for health professionals to use, so you may find the language more technical than the condition leaflets.
Nasal polyps are lesions arising from the nasal mucosa, occurring at any site in the nasal cavity or paranasal sinuses but most frequently seen in the clefts of the middle meatus. Nasal polyps can be considered as part of the spectrum of chronic rhinosinusitis. They must be distinguished from more serious pathology such as nasal tumours, particularly if they are unilateral. If they occur in children, cystic fibrosis testing is merited.
The exact pathogenesis is not known. Nasal polyps have been linked with chronic inflammation such as in chronic rhinosinusitis and vasculitis. Superantigens produced by Staphylococcus aureus may play a role. Polyps usually start close to the ostiomeatal complex (the sinus ostia) of the nasopharynx.
Histological examination reveals that in most polyps there are sac-like entities with an eosinophil-rich oedematous wall; their poor blood supply gives them a pale appearance. Over time, they may become fleshy and reddened due to squamous metaplasia. Benign and malignant nasal tumours can mimic or co-exist with nasal polyps.
Nasal polyps can be classified as eosinophil-rich (the most common type in the UK), infective, or due to other causes.
Recent research has identified differences in aetiology between chronic rhinitis with polyps and chronic rhinitis without polyps. Patients presenting with chronic rhinitis with polyps are found to have oedema of the nasal mucosa, low T regulator cell activity and low levels of beta-tissue growth factor. The opposite picture is seen with patients who have chronic rhinitis without polyps. Considerable variation exists globally. Different factors may be involved, depending on factors such as geographical location, culture and differences in bacterial colonisation.
- Aspirin sensitivity (see 'Aspirin-sensitive nasal polyposis', below)
- Cystic fibrosis (particularly nasal polyps in children)
- Allergic fungal sinusitis (rare in the UK but more common in warmer areas)
- Churg-Strauss syndrome
Nasal polyps are not associated with allergy.
Patients may have a history of recurring acute or chronic sinusitis. Symptoms depend on the size of the polyp (small polyps may be asymptomatic) and include:
- Nasal airway obstruction.
- Nasal discharge:
- Watery anterior rhinorrhoea, sneezing, postnasal drainage.
- Green secretions suggest infection (due to a polyp blocking the sinus ostia).
- Unilateral, blood-tinged secretion suggests a tumour, foreign body, nose picking, or misapplication of nasal spray.
- Dull headaches.
- Snoring and obstructive sleep symptoms.
- Hyposmia or anosmia (decreased smell) and reduced taste.
A nasal speculum will allow visualisation up until the anterior edge of the middle turbinate (in good conditions). Misting of the speculum helps confirm good airflow. The nose may be examined with an aural speculum if nasal equipment is lacking.
- Nasal polyps can be distinguished from the inferior turbinate by their lack of sensitivity, their yellowish-grey colour and by your ability to get between them and the side wall of the nose.
- The nasal bridge may be widened in patients with nasal polyps; it may be depressed in patients with Wegener's granulomatosis.
- Using an aural speculum, look for single, or clusters of, grape-like structures. Very large polyps may grow down into the oropharynx and can be visualised with a tongue depressor. Smaller polyps may not be visible without nasendoscopy.
- Decongestants and local anaesthesia may help examination.
- Nasal polyps tend to be bilateral. With unilateral lesions, suspect a tumour (and in children, rule out an encephalocele).
- Foreign body - particularly if there is unilateral, blood-tinged discharge in young children.
- Chronic rhinosinusitis without polyps.
- Allergic fungal rhinosinusitis.
- Tumours, benign and malignant - eg, nasopharyngeal carcinoma, dermoid tumour and others.
Be aware of associated conditions (see 'Associations', above), including cystic fibrosis in children with nasal polyps.
- Rigid or flexible endoscopy (rhinoscopy) carried out by specialists - this allows localisation and determination of the extent of the polyps.
- Plain X-ray films are of limited value - they are not recommended in this scenario.
- CT scans are helpful - they should be reserved for patients failing medical therapy or those with atypical or severe disease.
Investigation for an underlying cause
- Investigation of underlying chronic rhinosinusitis may be appropriate. This is detailed in guidelines.
- Patients with severe or recurrent polypoid rhinosinusitis merit investigations for aspirin sensitivity, allergic fungal rhinosinusitis or Churg-Strauss syndrome.
- All patients with polyps should initially be examined by an ENT surgeon.
- Unilateral polyps may be a sign of malignancy and should always be referred to ENT.
- Children with nasal polyps should be referred to be tested for cystic fibrosis.
- Review for associated/underlying disease (see 'Investigations, above) - eg, covert asthma and aspirin sensitivity.
- As there is no single causative factor, treatment targets the underlying inflammatory process.
- Medical management is first-line, unless the nature of the polyp is uncertain (eg, suspected malignancy).
- Patients should be educated regarding the recurring nature of this problem.
- These are the the mainstay of medical management: in most patients, they improve symptoms and reduce recurrence after surgery.
- Nasal drops are preferred to sprays for nasal polyps. They should be used in the 'head upside down' position (see diagram).
- Systemic absorption is negligible with mometasone and fluticasone, high for betamethasone and dexamethasone, and modest for the remainder.
- Fluticasone, mometasone and budesonide do not seem to affect children's growth - unlike beclometasone. However, take into account other steroid use (eg, chest and skin). Growth monitoring is advised for children.
- Patients with glaucoma should be monitored more closely.
- A medical polypectomy refers to the steroid regimen used to treat large polyps (see under 'Medical polypectomy', below).
- One study reported that use of topical steroids after surgery for nasal polyps had a significant effect on the prevention of recurrence. 
Other possible drugs are:
- Antihistamine (if allergic rhinitis is present).
- Nasal douche (saline) may be of moderate benefit especially when combined with other treatments (eg, steroids, antibiotics) but their use is not supported by evidence in the postoperative period.
- Leukotriene receptor antagonists are not supported by current guidelines.
- Antibiotic - one trial recommended some benefit from a three-week course of doxycycline but another trial was equivocal. Further studies are needed before conclusions can be drawn about longer courses.
- Azelastine was shown to be of benefit when combined with an antibiotic in a small study of patients with small polyps but further work is needed.
- Systemic corticosteroids - long-term use is not advised due to side-effects but a short course immediately after surgery has also been shown to have long-term benefits.
- There is insufficient evidence to recommend the use of anti-IgE antibodies.
Medical polypectomy: this is the regimen used to treat large polyps. It consists of oral prednisolone (0.5 mg/kg) for 5-10 days with betamethasone nasal drops two drops per nostril tds in the 'head upside down' position (see diagram) for five days, then twice daily until the bottle runs out. It is followed by maintenance therapy: fluticasone (drops, spray) or mometasone (spray) twice daily until the bottle runs out.
Steroid injection of polyps has been used but there are safety concerns.
The gold standard treatment is functional (as in restoring function) endoscopic sinus surgery (FESS). This has been found to be as safe and effective as more invasive procedures. Accepted practice is to reserve surgery for medically refractory cases but there are some authorities who hold that performing such a procedure early in the condition reduces exposure to the adverse effects of medical treatment (eg, antibiotics, topical steroids).
Severe complications are uncommon. Complications include:
- Acute bacterial sinusitis - with potential complications of intracranial infections (eg, meningitis); cavernous sinus thrombosis, orbital complications (periorbital and orbital cellulitis, orbital abscess); and subperiosteal abscess.
- Sleep disruption.
- May contribute to symptoms of asthma.
- Rarely, massive polyps (such as those occurring in cystic fibrosis or with allergic fungal sinusitis) can lead to craniofacial structural abnormalities with resulting proptosis, hypertelorism (increased interorbital distance) and diplopia.
There is no single curative treatment and recurrence is common, including after surgery.
Aspirin sensitivity associated with nasal polyposis, rhinosinusitis and asthma is called asthma-exacerbated respiratory disease (AERD). Hypersensitivity to aspirin or other non-steroidal anti-inflammatory drug (NSAID) is associated with a more severe and protracted course of nasal polyps and a distinct pattern of cellular, biochemical and molecular markers of inflammation. 60-70% of patients with aspirin-sensitive asthma have nasal polyps compared to 10% of asthma patients who are not sensitive to aspirin.
- Typically occurring in the third and fourth decades of life; more common in females and in non-atopics.
- Ingestion of aspirin or an NSAID induces a reproducible reaction within 20-120 minutes:
- In any individual the form of the reaction is consistent.
- Any combination of symptoms may occur, including systemic upset with facial flushing, perspiration and intense lethargy, rhinorrhoea, nasal congestion, conjunctivitis, respiratory symptoms (cough and bronchospasm) and gastrointestinal symptoms.
- A severe reaction can include shock and respiratory arrest.
Aspirin sensitivity should be suspected in patients with severe or recurrent nasal polyps and intrinsic asthma. The diagnosis relies on either a clear history of two aspirin/NSAID-induced reactions or by aspirin challenge (nasal, inhaled or oral).
Management of aspirin sensitivity
- Patients should be warned to avoid all drugs with cyclo-oxygenase-1 (COX-1) inhibitory activity. Selective COX-2 inhibitors appear to be safe but it is suggested that the first dose should be administered in hospital under direct observation with monitoring for two hours and resuscitation facilities available.
- Paracetamol is usually (not always) tolerated; single doses of ≤500 mg are safe in 94% of patients.
- A diet avoiding preservatives, additives and high salicylate foods may be helpful (for some patients in open studies).
- Aspirin desensitisation can be carried out in a hospital setting.
- Surgery is less successful (compared with aspirin-tolerant patients).
Further reading & references
- Wu AW, Ting JY, Platt MP, et al; Factors affecting time to revision sinus surgery for nasal polyps: a 25-year experience. Laryngoscope. 2014 Jan;124(1):29-33. doi: 10.1002/lary.24213. Epub 2013 Jul 29.
- Baradaranfar MH, Ahmadi ZS, Dadgarnia MH, et al; Comparison of the effect of endoscopic sinus surgery versus medical therapy on olfaction in nasal polyposis. Eur Arch Otorhinolaryngol. 2014 Feb;271(2):311-6. doi: 10.1007/s00405-013-2553-6. Epub 2013 May 23.
- Mainz JG, Koitschev A; Pathogenesis and management of nasal polyposis in cystic fibrosis. Curr Allergy Asthma Rep. 2012 Apr;12(2):163-74. doi: 10.1007/s11882-012-0250-y.
- Verbruggen K, Van Cauwenberge P, Bachert C; Anti-IgE for the treatment of allergic rhinitis--and eventually nasal polyps? Int Arch Allergy Immunol. 2009;148(2):87-98. Epub 2008 Sep 18.
- Fokkens WJ, Lund VJ, Mullol J, et al; European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl. 2012 Mar;(23)
- Bachert C, Van Bruaene N, Toskala E, et al; Important research questions in allergy and related diseases: 3-chronic Allergy. 2009 Apr;64(4):520-33.
- Newton JR, Ah-See KW; A review of nasal polyposis. Ther Clin Risk Manag. 2008 Apr;4(2):507-12.
- Guidelines for the management of rhinosinusitis and nasal polyposis; British Society for Allergy and Clinical Immunology (2007)
- Van Cauwenberge P, Van Zele T, Bachert C; Chronic rhinonsinusitis and nasal polyposis: the etiopathogenesis revealed? Verh K Acad Geneeskd Belg. 2008;70(5-6):305-22.
- Craig TJ, Ferguson BJ, Krouse JH; Sleep impairment in allergic rhinitis, rhinosinusitis, and nasal polyposis. Am J Otolaryngol. 2008 May-Jun;29(3):209-17. Epub 2008 Mar 19.
- Chaudhary N, Gupta N, Gudwani S, et al; Nasal encephalocoele -an atypical case. Indian J Otolaryngol Head Neck Surg. 2004 Jan;56(1):51-3. doi: 10.1007/BF02968776.
- Thomas M, Yawn BP, Price D, et al; EPOS Primary Care Guidelines: European Position Paper on the Primary Care Prim Care Respir J. 2008 Jun;17(2):79-89.
- Antunes MB, Becker SS; The role of local steroid injection for nasal polyposis. Curr Allergy Asthma Rep. 2010 May;10(3):175-80. doi: 10.1007/s11882-010-0104-4.
- Dalziel K, Stein K, Round A, et al; Endoscopic sinus surgery for the excision of nasal polyps: A systematic review of safety and effectiveness. Am J Rhinol. 2006 Sep-Oct;20(5):506-19.
- Klimek L, Pfaar O; Aspirin intolerance: does desensitization alter the course of the disease? Immunol Allergy Clin North Am. 2009 Nov;29(4):669-75.
Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. EMIS has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.
Dr Olivia Scott
Dr Laurence Knott
Dr Helen Huins